Constipation Clinical Trial
Constipation is a symptom based disorder with a prevalence of 15% in the adult population and
its management remains challenging. Although not life threatening, constipation is associated
with impaired quality of life, increased healthcare costs and excess work absenteeism.
Constipation represents a heterogeneous disorder with a multifactorial pathogenesis. Several
risk factors have been suggested to lead to the condition and are divided in 3 main
categories: a) physiological, b) environmental and c) demographic. To date, there is lack of
large epidemiological studies on proposed aetiological factors of constipation, especially
studies assessing all proposed risk factors of constipation together.
The overall aim of this study is to investigate the multidimensional (physiological,
environmental and demographic) predictors of constipation with the use of a multivariate
analysis statistical model.
This is a large single centre case control study comparing constipated adults with healthy
individuals matched for age, gender and ethnicity.
The duration of the study is 2 weeks in total and includes a screening visit, a 2 week run-in
period and a baseline visit at the end of the run-in period. Transit time between constipated
and healthy individuals is assessed at baseline visit. Differences in gastrointestinal
symptoms, dietary intake as well as differences in stool output (e.g. stool frequency and
consistency) between constipated and healthy individuals are assessed over the baseline
period (the week before the baseline visit). Differences in female sex hormone levels as well
as stool markers and markers of fermentation (e.g. fecal water, stool pH, short chain fatty
acids) between constipated and healthy individuals are assessed at baseline visit.
Furthermore, differences in environmental measures (physical activity, anxiety, smoking) and
differences in demographic measures (age, gender, body mass index) between patients suffering
from constipation and healthy individuals are also assessed at baseline visit.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Recruiting |
NCT06292949 -
Clinical Study of Resistant Starch in Improving Constipation
|
N/A | |
Recruiting |
NCT04132661 -
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
|
Phase 4 | |
Completed |
NCT02726295 -
The Efficacy of Mutaflor(E. Coli Nissle 1917, Mutaflor®) for Chronic Constipation:Multicenter Study
|
Phase 4 | |
Terminated |
NCT02839889 -
Tolerability, Safety, and Feasibility of Naloxegol in Patients With Cancer and OIC (Opioid Induced Constipation)
|
Phase 4 | |
Recruiting |
NCT02255747 -
Anal Dilatation for Infants and Children With Constipation
|
N/A | |
Completed |
NCT02246647 -
Biomarkers for Intestinal Permeability in Patients With Constipation
|
||
Completed |
NCT01566409 -
Maintenance Treatment for Children With Constipation
|
N/A | |
Completed |
NCT02863848 -
Effect of Inulin-type Fructans on Constipated Children.
|
N/A | |
Completed |
NCT01710579 -
Normal Values in Ano-rectal 3D High Resolution Manometry
|
N/A | |
Completed |
NCT02658201 -
Ultrafast MRI Imaging to Exclude Constipation
|
N/A | |
Completed |
NCT01695915 -
Diurnal Variation in Rectal Diameter
|
N/A | |
Completed |
NCT01474499 -
A Trial of Docusate Sodium and Sorbitol Rectal Solution for the in Patients With Constipation
|
Phase 3 | |
Completed |
NCT01438567 -
A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy
|
Phase 3 | |
Completed |
NCT01411501 -
Efficacy and Safety of Acupuncture for Functional Constipation
|
Phase 3 | |
Completed |
NCT00931853 -
Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).
|
Phase 3 | |
Completed |
NCT01170039 -
The Effectiveness of Lubiprostone in Constipated Diabetics
|
Phase 4 | |
Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
Completed |
NCT00994851 -
Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 |